Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Glicwel 40
Glicwel 40 (Gliclazide Tablets 40 mg) is an advanced oral hypoglycemic agent designed for individuals with type 2 diabetes mellitus. It plays a crucial role in maintaining optimal blood sugar levels, reducing the risk of long-term complications, and promoting overall metabolic health.
Uses of Glicwel 40
Glicwel 40 is primarily used to manage type 2 diabetes in patients who require better glycemic control. It stimulates pancreatic β-cells to enhance insulin secretion, thereby reducing blood glucose levels. It is prescribed as part of a comprehensive diabetes management plan, including diet and exercise.
Benefits of Glicwel 40
Effective Glycemic Control: Enhances insulin secretion to regulate blood sugar.
Reduces Diabetes-Related Complications: Lowers the risk of cardiovascular diseases and neuropathy.
Controlled-Release Action: Provides sustained therapeutic effect with reduced fluctuations in blood glucose.
Convenient Dosage: Once-daily formulation ensures patient compliance.
Mechanism of Action of Glicwel 40
Gliclazide, the active ingredient in Glicwel 40, belongs to the sulfonylurea class and functions by stimulating insulin secretion from pancreatic β-cells. It binds to sulfonylurea receptors, triggering insulin release and improving glucose utilization. Additionally, it exhibits antioxidant and anti-inflammatory properties, which contribute to vascular protection in diabetic patients.